Diacetyl hexamethylene diamine

N/A

Report date: 2022/12/10 22:19:54
NME

Base Information

Drug NameDiacetyl hexamethylene diamine
Drug Alias NameCAHBMHAD
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis inducers
TargetsNot applicable
Therapy Area/IndicationsMyelodysplastic Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesWuxi Shanhe Group No 1 Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuxi Shanhe Group No 1 Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsMyelodysplastic Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A